Effectiveness and Cost-Effectiveness of Expanded Targeted Testing and Treatment of Latent Tuberculosis Infection Among the Medicare Population in 2022

Authors

Garrett R. Beeler Asay
Carla A. Winston (ORCID: https://orcid.org/0000-0003-0261-966X)
Nicole A. Swartwood (ORCID: https://orcid.org/0000-0003-4116-9243)
Joshua A. Salomon (ORCID: https://orcid.org/0000-0003-3929-5515)
Suzanne M. Marks (ORCID: https://orcid.org/0000-0003-3024-1940)
Ted Cohen (ORCID: https://orcid.org/0000-0002-8091-7198)
Nicolas A. Menzies (ORCID: https://orcid.org/0000-0002-2571-016X)
Dawn Pepin (ORCID: https://orcid.org/0000-0002-0128-2949)
Yunfei Li (ORCID: https://orcid.org/0000-0002-6891-5392)
C. Robert Horsburgh (ORCID: https://orcid.org/0000-0001-6838-7895)
Susan McClure (ORCID: https://orcid.org/0009-0004-8617-0349)

Institutions

Boston University (US)
Centers for Disease Control and Prevention (US)
National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention (US)
Boston Public Schools (US)
Harvard Global Health Institute (US)
Stanford University (US)

Publication Details

Journal: Annals of Internal Medicine
Published: 2025-02-07
DOI: https://doi.org/10.7326/annals-24-00870
Citations: 3
Primary Topic: Tuberculosis Research and Epidemiology
Type: article
Field-Weighted Citation Impact: 4.19

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Effectiveness and Cost-Effectiveness of Expanded Targeted Testing and Treatment of Latent Tuberculosis Infection Among the Medicare Population in 2022

Garrett R. Beeler Asay, Carla A. Winston, Nicole A. Swartwood, Joshua A. Salomon et al.

Feb 7, 2025

3 citations

Annals of Internal Medicine

Tuberculosis Research and Epidemiology

4.19

article

Effectiveness and Cost-Effectiveness of Expanded Targeted Testing and Treatment of Latent Tuberculosis Infection Among the Medicare Population in 2022

Garrett R. Beeler Asay, Carla A. Winston, Nicole A. Swartwood, Joshua A. Salomon, Suzanne M. Marks, Ted Cohen, Nicolas A. Menzies, Dawn Pepin, Yunfei Li, C. Robert Horsburgh, Susan McClure

February 7, 2025article en

3 citations

Abstract

No abstract available for this paper.

Annals of Internal MedicineVol. 178(4)

Boston University (US), Centers for Disease Control and Prevention (US), National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention (US), Boston Public Schools (US), Harvard Global Health Institute (US), Stanford University (US)

Good health and well-being

Openalex Percentile: Top 7%

Tuberculosis Research and Epidemiology

4.19

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Effectiveness and Cost-Effectiveness of Expanded Targeted Testing and Treatment of Latent Tuberculosis Infection Among the Medicare Population in 2022 — Garrett R. Beeler Asay, Carla A. Winston, et al. · Annals of Internal Medicine (2025) | TGRS Research Map | TGRS